ResearchCurrent Research Project 

  1. Pfizer Laboratories: Double-blind, triple dummy, parallel-group, randomised, six-month study to compare celecoxib (200 mg bid) with diclofenac SR (75 mg bid) plus omeprazole (20 mg qd) for gastrointestinal events in subjects with osteoarthritis and rheumatoid arthritis at high risk of gastrointestinal adverse events (Awaiting ethical approval).

Share This Page